A Review of the Evidence to Support Influenza Vaccine Introduction in Countries and Areas of WHO's Western Pacific Region

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Samaan, Gina ^a   McPherson, Michelle ^a   Partridge, Jeffrey ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG QUALITY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INCIDENCE; INCOME; INFLUENZA VACCINATION; PANDEMIC INFLUENZA; POPULATION RESEARCH; PREGNANT WOMAN; PREVALENCE; PUBLIC HEALTH PROBLEM; SEASONAL INFLUENZA; SOCIOECONOMICS; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION;

FEMALE; HUMANS; INFLUENZA VACCINES; MALE; PREGNANCY; WORLD HEALTH ORGANIZATION;

EID: 84880466244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070003     Document Type: Article

References (141)

1. World Health Organization (2005) Countries and areas. Available: www.wpro.who.int/countries/list.htm. Accessed 2011 November 23.
2. World Health Organization (2010) National Influenza Centres. Available: www.who.int/csr/disease/influenza/centres/en/index.html. Accessed 2011 March 15.
3. World Health Organization (2005) Vaccine Introduction Guidelines. Adding a vaccine to a national immunization programme: decision and implementation. Available: http://www.who.int/vaccines-documents/DoxGen/H3DoxList.htm. Accessed 2011 November 1.
4. World Health Organization (2012) Vaccines against influenza WHO position paper- November 2012. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 87: 461-476.
5. World Bank (2011) Country classifications Available: http://data.worldbank.org/about/country-classifications/country-and-lending-groups. Accessed 2011 March 15.
6. Seale H, Leask J, MacIntyre CR, (2011) Attitudes amongst Australian hospital healthcare workers towards seasonal influenza and vaccination. Influenza Other Respi Viruses 4: 41-46.
7. Murray SB, Skull SA, (2002) Poor health care worker vaccination coverage and knowledge of vaccination recommendations in a tertiary Australia hospital. Aust N Z J Public Health 26: 65-68.
8. Seale H, Wang Q, Yang P, Dwyer DE, Wang X, et al. Influenza vaccination amongst hospital health care workers in Beijing. Occup Med (Lond) 60: 335-339.
9. Ridda I, Lindley IR, Gao Z, McIntyre P, Macintyre CR, (2008) Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine 26: 5633-5640.
10. Brunton C, Weir R, Jennings L, (2005) Knowledge and attitudes about influenza vaccination amongst general practitioners, practice nurses, and people aged 65 and over. N Z Med J 118: U1434.
11. Ward K, Seale H, Zwar N, Leask J, Macintyre CR, (2011) Annual influenza vaccination: coverage and attitudes of primary care staff in Australia. Influenza Other Respi Viruses 5: 135-141.
12. Wong SY, Wong EL, Chor J, Kung K, Chan PK, et al. (2010) Willingness to accept H1N1 pandemic influenza vaccine: a cross-sectional study of Hong Kong community nurses. BMC infectious diseases 10: 316.
13. Lau JT, Yang X, Tsui HY, Kim JH, (2006) Prevalence of influenza vaccination and associated factors among community-dwelling Hong Kong residents of age 65 or above. Vaccine 24: 5526-5534.
14. Mok E, Yeung SH, Chan MF, (2006) Prevalence of influenza vaccination and correlates of intention to be vaccinated among Hong Kong Chinese. Public Health Nurs 23: 506-515.
15. Kee SY, Lee JS, Cheong HJ, Chun BC, Song JY, et al. (2007) Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 55: 273-281.
16. Curry E, Kerr N, Yang J, Briggs S, (2006) Influenza immunisation rate for 2005 and factors associated with receiving this vaccine in patients aged 65 years and over admitted to a general medical ward at Auckland City Hospital. N Z Med J 119: U2254.
17. Kwong EW, Lam IO, Chan TM, (2009) What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics? J Clin Nurs 18: 960-971.
18. Tan EK, Lim LH, Teoh YL, Ong G, Bock HL, Influenza and seasonal influenza vaccination among diabetics in Singapore: knowledge, attitudes and practices. Singapore Med J 51: 623-630.
19. Takahashi O, Noguchi Y, Rahman M, Shimbo T, Goto M, et al. (2003) Influence of family on acceptance of influenza vaccination among Japanese patients. Fam Pract 20: 162-166.
20. Lau JT, Cai Y, Tsui HY, Choi KC, (2010) Prevalence of influenza vaccination and associated factors among pregnant women in Hong Kong. Vaccine 28: 5389-5397.
21. White SW, Petersen RW, Quinlivan JA, (2010) Pandemic (H1N1) 2009 influenza vaccine uptake in pregnant women entering the 2010 influenza season in Western Australia. Med J Aust 193: 405-407.
22. Siu W, Fear appeals and public service advertising: applications to influenza in Hong Kong. Health Commun 25: 580.
23. Seale H, Heywood AE, McLaws ML, Ward KF, Lowbridge CP, et al. Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine. BMC Infect Dis 10: 99.
24. Kwong EW, Pang SM, Choi PP, Wong TK, (2010) Influenza vaccine preference and uptake among older people in nine countries. J Adv Nurs 66: 2297-2308.
25. Gill TK, Taylor AW, Watson M, (2007) Trends in influenza immunisation amongst an elderly Australian community. Vaccine 25: 5428-5432.
26. Kwong EW, Lam IO, (2008) Chinese older people in Hong Kong: health beliefs about influenza vaccination. Nurs Older People 20: 29-33.
27. Lau JT, Yeung NC, Choi KC, Cheng MY, Tsui HY, et al. (2009) Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. Bmj 339: b4164.
28. Lau JT, Kim JH, Yang X, Tsui HY, (2008) Cross-sectional and longitudinal factors predicting influenza vaccination in Hong Kong Chinese elderly aged 65 and above. J Infect 56: 460-468.
29. Gill T, Taylor AW, Kempe A, Pickering S, Watson M, (2005) Prevalence of influenza vaccination in South Australian aged care homes. Aust N Z J Public Health 29: 38-43.
30. Chor JS, Ngai KL, Goggins WB, Wong MC, Wong SY, et al. (2009) Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. Bmj 339: b3391.
31. Crawford NW, Heath JA, Ashley D, Downie P, Buttery JP, (2010) Survivors of childhood cancer: an Australian audit of vaccination status after treatment. Pediatr Blood Cancer 54: 128-133.
32. de Lataillade C, Auvergne S, Delannoy I, (2009) 2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East. J Public Health Policy 30: 83-101.
33. Puzelli S, Boros S, Affinito C, Calzoletti L, Facchini M, et al. (2006) Prevalence of antibodies against A and B influenza viruses in South-Western Papua New Guinea. J Med Virol 78: 820-824.
34. Leo YS, Lye DC, Barkham T, Krishnan P, Seow E, et al. (2010) Pandemic (H1N1) 2009 surveillance and prevalence of seasonal influenza, Singapore. Emerg Infect Dis 16: 103-105.
35. Phuong HL, Nga TT, van Doornum GJ, Groen J, Binh TQ, et al. (2010) Viral respiratory tract infections among patients with acute undifferentiated fever in Vietnam. Southeast Asian J Trop Med Public Health 41: 1116-1126.
36. Ng TP, Pwee KH, Niti M, Goh LG, (2002) Influenza in Singapore: assessing the burden of illness in the community. Ann Acad Med Singapore 31: 182-188.
37. Wada T, Morishima T, Okumura A, Tashiro M, Hosoya M, et al. (2009) Differences in clinical manifestations of influenza-associated encephalopathy by age. Microbiol Immunol 53: 83-88.
38. Huang QS, Lopez LD, McCallum L, Adlam B, (2008) Influenza surveillance and immunisation in New Zealand, 1997-2006. Influenza Other Respi Viruses 2: 139-145.
39. Flint SM, Davis JS, Su JY, Oliver-Landry EP, Rogers BA, et al. (2010) Disproportionate impact of pandemic (H1N1) 2009 influenza on Indigenous people in the Top End of Australia's Northern Territory. Med J Aust 192: 617-622.
40. Nelson EA, Tam JS, Yu LM, Li AM, Chan PK, et al. (2007) Assessing disease burden of respiratory disorders in Hong Kong children with hospital discharge data and linked laboratory data. Hong Kong Med J 13: 114-121.
41. Tang JW, Lai FY, Wong F, Hon KL, (2010) Incidence of common respiratory viral infections related to climate factors in hospitalized children in Hong Kong. Epidemiol Infect 138: 226-235.
42. Seah SG, Lim EA, Kok-Yong S, Liaw JC, Lee V, et al. (2010) Viral agents responsible for febrile respiratory illnesses among military recruits training in tropical Singapore. J Clin Virol 47: 289-292.
43. Tang JW, Lai FY, Nymadawa P, Deng YM, Ratnamohan M, et al. (2010) Comparison of the incidence of influenza in relation to climate factors during 2000-2007 in five countries. J Med Virol 82: 1958-1965.
44. Lau EH, Cowling BJ, Ho LM, Leung GM, (2008) Optimizing use of multistream influenza sentinel surveillance data. Emerg Infect Dis 14: 1154-1157.
45. Mermond S, Berlioz-Arthaud A, Estivals M, Baumann F, Levenes H, et al. (2010) Aetiology of community-acquired pneumonia in hospitalized adult patients in New Caledonia. Trop Med Int Health 15: 1517-1524.
46. Yu H, Feng L, Peng Z, Feng Z, Shay DK, et al. (2009) Estimates of the impact of a future influenza pandemic in China. Influenza Other Respi Viruses 3: 223-231.
47. Beard F, McIntyre P, Gidding H, Watson M, (2006) Influenza related hospitalisations in Sydney, New South Wales, Australia. Arch Dis Child 91: 20-25.
48. Yap FH, Ho PL, Lam KF, Chan PK, Cheng YH, et al. (2004) Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 73: 617-623.
49. Wong CM, Yang L, Chan KP, Leung GM, Chan KH, et al. (2006) Influenza-associated hospitalization in a subtropical city. PLoS Med 3: e121.
50. Li CK, Choi BC, Wong TW, (2006) Influenza-related deaths and hospitalizations in Hong Kong: a subtropical area. Public Health 120: 517-524.
51. Tomizuka T, Takayama Y, Shobayashi T, Fukushima Y, Suzuki Y, (2010) Underlying medical conditions and hospitalization for pandemic (H1N1) 2009, Japan. Emerging infectious diseases 16: 1646-1647.
52. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS, (2002) Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 347: 2097-2103.
53. Chiu SS, Chan KH, Chen H, Young BW, Lim W, et al. (2009) Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis 49: 1016-1021.
54. D'Onise K, Raupach JC, (2008) The burden of influenza in healthy children in South Australia. Med J Aust 188: 510-513.
55. Kwong KL, Lung D, Wong SN, Que TL, Kwong NS, (2009) Influenza-related hospitalisations in children. J Paediatr Child Health 45: 660-664.
56. Shin SY, Kim JH, Kim HS, Kang YA, Lee HG, et al. (2010) Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus. Pediatr Pulmonol 45: 1014-1020.
57. Verrall A, Norton K, Rooker S, Dee S, Olsen L, et al. (2010) Hospitalizations for pandemic (H1N1) 2009 among Maori and Pacific Islanders, New Zealand. Emerg Infect Dis 16: 100-102.
58. Drennan K, Hicks P, Hart G, (2010) Impact of pandemic (H1N1) 2009 on Australasian critical care units. Crit Care Resusc 12: 223-229.
59. Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, Kamarulzaman A, et al. (2010) High direct healthcare costs of patients hospitalised with pandemic (H1N1) 2009 influenza in Malaysia. The Journal of infection 61: 440-442.
60. Lee VJ, Yap J, Ong JB, Chan KP, Lin RT, et al. (2009) Influenza excess mortality from 1950-2000 in tropical Singapore. PLoS One 4: e8096.
61. Chow A, Ma S, Ling AE, Chew SK, (2006) Influenza-associated deaths in tropical Singapore. Emerg Infect Dis 12: 114-121.
62. He J, Gu D, Wu X, Reynolds K, Duan X, et al. (2005) Major causes of death among men and women in China. N Engl J Med 353: 1124-1134.
63. Wong CM, Chan KP, Hedley AJ, Peiris JS, (2004) Influenza-associated mortality in Hong Kong. Clin Infect Dis 39: 1611-1617.
64. Yang L, Wong CM, Chan KP, Chau PY, Ou CQ, et al. (2009) Seasonal effects of influenza on mortality in a subtropical city. BMC Infect Dis 9: 133.
65. Sugaya N, Takeuchi Y, (2005) Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan. Clin Infect Dis 41: 939-947.
66. Reichert TA, Sugaya N, Fedson DS, Glezen P, Simonsen L, et al. (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344: 889-896.
67. Takahashi H, Tanaka Y, Ohyama T, Sunagawa T, Nakashima K, et al. (2001) Evaluation of a mass influenza vaccination campaign. Jpn J Infect Dis 54: 184-188.
68. Zhu FC, Zhou W, Pan H, Lu L, Gerez L, et al. (2008) Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China. Vaccine 26: 4579-4584.
69. Kawai N, Ikematsu H, Iwaki N, Satoh I, Kawashima T, et al. (2003) A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine 21: 4507-4513.
70. Ono S, Kudo M, Aoki K, Ezaki F, Misumi J, (2003) Effect of mass immunization against influenza encephalopathy on mortality rates in children. Pediatr Int 45: 680-687.
71. Sasaki Y, Kusuhara K, Saito M, Hikino S, Murayama Y, et al. (2006) Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants. Vaccine 24: 2208-2212.
72. Kamada M, Nagai T, Kumagai T, Igarashi M, Ihara T, et al. (2006) Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season. Vaccine 24: 3618-3623.
73. Block SL, Toback SL, Yi T, Ambrose CS, (2009) Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years. Clin Ther 31: 2140-2147.
74. Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, et al. (2008) Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Vaccine 26: 2700-2705.
75. Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, et al. (2007) Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 26: 619-628.
76. Nolan T, Richmond PC, McVernon J, Skeljo MV, Hartel GF, et al. (2009) Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children. Influenza Other Respi Viruses 3: 315-325.
77. Deguchi Y, Nishimura K, (2001) Efficacy of Influenza Vaccine in Elderly Persons in Welfare Nursing Homes: Reduction in Risks of Mortality and Morbidity During an Influenza A (H3N2) Epidemic. J Gerontol A Biol Sci Med Sci 56: M391-394.
78. Hung IF, Leung AY, Chu DW, Leung D, Cheung T, et al. (2010) Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 51: 1007-1016.
79. Miyagawa K, Hayashi Y, Kurihara S, Maeda A, (2008) Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity. Geriatr Gerontol Int 8: 243-250.
80. Di B, Xu X, Li T, Lu E, Wu J, et al. (2010) Immunogenicity associated with the routine use of an influenza A H1N1 vaccine in health care personnel in Guangzhou, China. Clin Vaccine Immunol 17: 1478-1480.
81. Kheok SW, Chong CY, McCarthy G, Lim WY, Goh KT, et al. (2008) The efficacy of influenza vaccination in healthcare workers in a tropical setting: a prospective investigator blinded observational study. Ann Acad Med Singapore 37: 465-469.
82. Song JY, Cheong HJ, Ha SH, Kee SY, Jeong HW, et al. (2006) Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination. Am J Nephrol 26: 206-211.
83. Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 375: 56-66.
84. Wu J, Zhong X, Li CK, Zhou JF, Lu M, et al. (2011) Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. Vaccine 29: 1009-1016.
85. Cheong HJ, Song JY, Heo JY, Noh JY, Choi WS, et al. (2011) Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea. Vaccine 29: 523-527.
86. Cowling BJ, Ng S, Ma ES, Cheng CK, Wai W, et al. (2010) Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 51: 1370-1379.
87. Liu W, de Vlas SJ, Tang F, Ma MJ, Wei MT, et al. (2010) Clinical and immunological characteristics of patients with 2009 pandemic influenza A (H1N1) virus infection after vaccination. Clin Infect Dis 51: 1028-1032.
88. Ikematsu H, Nagai H, Kawashima M, Kawakami Y, Tenjinbaru K, et al. (2010) Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan. Hum Vaccin 6: 888-893.
89. Lee VJ, Tay JK, Chen MI, Phoon MC, Xie ML, et al. (2010) Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 28: 6852-6857.
90. Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, et al. (2009) Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. Jama 303: 37-46.
91. Igari H, Segawa S, Watanabe A, Suzuki A, Watanabe M, et al. (2010) Immunogenicity of a monovalent pandemic influenza A H1N1 vaccine in health-care workers of a university hospital in Japan. Microbiol Immunol 54: 618-624.
92. Chu DW, Hwang SJ, Lim FS, Oh HM, Thongcharoen P, et al. (2009) Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. Vaccine 27: 7428-7435.
93. Hirota Y, (2008) Ecological fallacy and scepticism about influenza vaccine efficacy in Japan: the Maebashi study. Vaccine 26: 6473-6476.
94. Ochiai H, Fujieda M, Ohfuji S, Fukushima W, Kondo K, et al. (2009) Inactivated influenza vaccine effectiveness against influenza-like illness among young children in Japan-with special reference to minimizing outcome misclassification. Vaccine 27: 7031-7035.
95. Gotoh K, Ito Y, Suzuki E, Kaneko K, Kiuchi T, et al. (2011) Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons. Pediatr Transplant 15: 112-116.
96. Hara M, Sakamoto T, Tanaka K, (2006) Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan. Vaccine 24: 5546-5551.
97. Hara M, Tanaka K, Kase T, Maeda A, Hirota Y, (2010) Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan. Vaccine 28: 5664-5668.
98. Deguchi Y, Takasugi Y, Nishimura K, (2000) Vaccine effectiveness for influenza in the elderly in welfare nursing homes during an influenza A (H3N2) epidemic. Epidemiol Infect 125: 393-397.
99. Ozasa K, Kawahito Y, Doi T, Watanabe Y, Washio M, et al. (2006) Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan. Vaccine 24: 2537-2543.
100. Otsuka T, Fujinaka H, Katsuyama K, Iizawa M, Kinoshita S, et al. (2007) Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season. Vaccine 25: 4521-4524.
101. Kelly H, Carville K, Grant K, Jacoby P, Tran T, et al. (2009) Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One 4: e5079.
102. Yamaguchi S, Ohfuji S, Hirota Y, (2010) Influenza vaccine effectiveness in primary school children in Japan: a prospective cohort study using rapid diagnostic test results. J Infect Chemother 16: 407-413.
103. Carlson SJ, Durrheim DN, Dalton CB, (2010) Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007-2009. Vaccine 28: 6809-6810.
104. Lee CS, Lee KH, Jung MH, Lee HB, (2008) Rate of influenza vaccination and its adverse reactions seen in health care personnel in a single tertiary hospital in Korea. Jpn J Infect Dis 61: 457-460.
105. Mahajan D, Roomiani I, Gold MS, Lawrence GL, McIntyre PB, et al. (2010) Annual report: surveillance of adverse events following immunisation in Australia, 2009. Commun Dis Intell 34: 259-276.
106. Park SW, Lee JH, Kim ES, Kwak YG, Moon CS, et al. (2011) Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers. Am J Infect Control 39: 69-71.
107. Park JH, Cheong HK, Son DY, Kim SU, Ha CM, (2010) Perceptions and behaviors related to hand hygiene for the prevention of H1N1 influenza transmission among Korean university students during the peak pandemic period. BMC Infect Dis 10: 222.
108. Cowling BJ, Chan KH, Fang VJ, Cheng CK, Fung RO, et al. (2009) Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 151: 437-446.
109. Dan YY, Tambyah PA, Sim J, Lim J, Hsu LY, et al. (2009) Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat. Emerg Infect Dis 15: 1909-1916.
110. Cheng VC, Tai JW, Wong LM, Chan JF, Li IW, et al. (2009) Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect 74: 271-277.
111. Sasaki A, Hoen AG, Ozonoff A, Suzuki H, Tanabe N, et al. (2009) Evidence-based tool for triggering school closures during influenza outbreaks, Japan. Emerg Infect Dis 15: 1841-1843.
112. Cowling BJ, Lau EH, Lam CL, Cheng CK, Kovar J, et al. (2008) Effects of school closures, 2008 winter influenza season, Hong Kong. Emerg Infect Dis 14: 1660-1662.
113. Wong CM, Lai HK, Ou CQ, Ho SY, Chan KP, et al. (2008) Is exercise protective against influenza-associated mortality? PLoS One 3: e2108.
114. Yamada H, Takuma N, Daimon T, Hara Y, (2006) Gargling with tea catechin extracts for the prevention of influenza infection in elderly nursing home residents: a prospective clinical study. J Altern Complement Med 12: 669-672.
115. Wu JT, Lee CK, Cowling BJ, Yuen KY, (2010) Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Natl Acad Sci U S A 107: 3269-3274.
116. Lu CJ, Luo Y, Zhou H, Qin XL, Chen BJ, et al. (2010) A preliminary study on the medical expenditure of Chinese medicine and integrative medicine treatment for influenza A (H1N1) in the fever clinics. Chin J Integr Med 16: 493-497.
117. Kelso JK, Halder N, Milne GJ, (2010) The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009. PLoS One 5: e13797.
118. Lee VJ, Yap J, Cook AR, Chen MI, Tay JK, et al. (2010) Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study. J Infect Dis 202: 1319-1326.
119. Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR, (2008) The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia. Vaccine 26: 2142-2153.
120. Cai L, Uchiyama H, Yanagisawa S, Kamae I, (2006) Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan. Kobe J Med Sci 52: 97-109.
121. Hoshi SL, Kondo M, Honda Y, Okubo I, (2007) Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan. Vaccine 25: 6511-6521.
122. Mogasale V, Barendregt J, (2011) Cost-effectiveness of influenza vaccination of people aged 50-64 years in Australia: results are inconclusive. Aust N Z J Public Health 35: 180-186.
123. Kelly H, Attia J, Andrews R, Heller RF, (2004) The number needed to vaccinate (NNV) and population estimates of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over. Vaccine 22: 2192-2198.
124. Ohkusa Y, (2005) Policy evaluation for the subsidy for influenza vaccination in elderly. Vaccine 23: 2256-2260.
125. Kondo M, Hoshi SL, Okubo I, (2009) Does subsidy work? Price elasticity of demand for influenza vaccination among the elderly in Japan. Health Policy 91: 269-276.
126. Fitzner KA, Shortridge KF, McGhee SM, Hedley AJ, (2001) Cost-effectiveness study on influenza prevention in Hong Kong. Health Policy 56: 215-234.
127. Newall AT, Wood JG, Oudin N, MacIntyre CR, (2010) Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies. Emerg Infect Dis 16: 224-230.
128. Lee VJ, Tok MY, Chow VT, Phua KH, Ooi EE, et al. (2009) Economic analysis of pandemic influenza vaccination strategies in Singapore. PLoS One 4: e7108.
129. Feng L, Mounts AW, Feng Y, Luo Y, Yang P, et al. (2010) Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009. Vaccine 28: 6778-6782.
130. Gronvall GK, Borio LL, (2006) Removing barriers to global pandemic influenza vaccination. Biosecur Bioterror 4: 168-175.
131. Morimoto T, Ishikawa H, (2010) Evaluation of vaccination strategies to suppress a novel influenza pandemic using an individual-based model. Nihon Eiseigaku Zasshi 65: 459-466.
132. Blackmore T (2005) Sole supply of influenza vaccine: economic common sense or a disaster waiting to happen? N Z Med J 118: U1596; discussion U1601.
133. Masuda M, Sugita S, Kuroda K, Nishimura H, (2009) H5N1 influenza vaccination policy in Japan. Lancet Infect Dis 9: 266-267.
134. The Macroepidemiology of Influenza Vaccination (MIV) Study Group (2005) The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 23: 5133-5143.
135. Lee HY, Fong YT, (2007) On-site influenza vaccination arrangements improved influenza vaccination rate of employees of a tertiary hospital in Singapore. Am J Infect Control 35: 481-483.
136. Ballestas T, McEvoy SP, Doyle J, (2009) Co-ordinated approach to healthcare worker influenza vaccination in an area health service. J Hosp Infect 73: 203-209.
137. Hirota Y, Kaji M, (2008) History of influenza vaccination programs in Japan. Vaccine 26: 6451-6454.
138. Partridge J, Kieny MP, (2010) Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 28: 4709-4712.
139. World Health Organization (2005) Global Influenza Surveillance and Response System (GISRS) Available: http://www.who.int/influenza/gisrs_laboratory/en/. Accessed 2011 October 20.
140. World Health Organization (2011) Global action plan for influenza vaccines. Available: www.who.int/influenza_vaccines_plan/objectives/en/. Accessed 2012 January 7.
141. Gonzalez-Block MA, (2004) Health policy and systems research agendas in developing countries. Health Res Policy Syst 2: 6.